Related Experiment Video

Updated: May 3, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.3K

Prevention of macrovascular disease in patients with short-duration type 2 diabetes by multifactorial target control:

Wen-xia Wu1, Meng Ren, Hua Cheng

  • 1Department of Endocrinology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120, China.

Endocrine
|January 24, 2014
PubMed

Insights

Multifactorial treatment targeting blood pressure and glucose levels in early type 2 diabetes significantly reduces the risk of atherosclerosis and cardiovascular disease complications.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 2 diabetes is a growing global health concern.
  • Macrovascular complications are a leading cause of morbidity and mortality in diabetic patients.
  • Early intervention is crucial for preventing long-term diabetic complications.

Purpose of the Study:

  • To investigate the impact of American Diabetes Association (ADA)-recommended multifactorial target control on macrovascular disease in patients with short-duration type 2 diabetes.
  • To assess the effectiveness of managing hyperglycemia, hypertension, and dyslipidemia in preventing atherosclerosis and cardiovascular events.

Main Methods:

  • A longitudinal prospective study involving 143 patients with newly diagnosed or short-duration type 2 diabetes without prior vascular disease.
  • Patients received pharmacologic therapy targeting hyperglycemia, hypertension, dyslipidemia, and aspirin for secondary prevention as per ADA guidelines.
  • Arterial ultrasounds (carotid, iliac, femoral) were performed annually for 8 years to monitor atherosclerosis plaque development.
  • Primary endpoint: time to first occurrence of atherosclerosis plaques. Secondary endpoint: clinical cardiovascular diseases.

Main Results:

  • Systolic blood pressure < 130 mmHg (HR 0.236) and fasting plasma glucose < 7 mmol/l (HR 0.457) were significantly associated with reduced atherosclerosis onset.
  • Simultaneous target control of systolic blood pressure and fasting plasma glucose decreased the risk of atherosclerosis plaques by 18% (P=0.097).
  • This multifactorial approach also reduced the risk of cardiovascular diseases by 16% (P=0.046).

Conclusions:

  • Multifactorial target treatment, focusing on blood pressure and glucose control, is effective in reducing macrovascular complications in early-stage type 2 diabetes.
  • Achieving target systolic blood pressure and fasting plasma glucose levels are key factors in preventing atherosclerosis progression.
  • Early and comprehensive management of risk factors in type 2 diabetes can significantly mitigate long-term cardiovascular risks.

More Related Videos

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.9K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75